Are Wall Street Analysts Bullish on Bio-Techne Stock?

With a market cap of $7.5 billion, Bio-Techne Corporation (TECH) is a global life sciences company that develops, manufactures, and sells reagents, instruments, and services for research, diagnostics, and bioprocessing applications. It operates through its Protein Sciences and Diagnostics and Spatial Biology segments, providing innovative solutions for life science research, cell and gene therapy, molecular diagnostics, and spatial biology.

Shares of Bio-Techne have lagged behind the broader market over the past 52 weeks. HCA stock has risen 1.9% over this time frame, while the broader S&P 500 Index ($SPX) has gained 27.9%. In addition, the stock has declined 18% on a YTD basis, compared to SPX's 9.2% return.